| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8629967 | Diabetes Research and Clinical Practice | 2018 | 7 Pages |
Abstract
In conclusion, PPI use was not associated with the subsequent risk of development or progression of albuminuria, or eGFR decline in patients with diabetes.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
![Association of proton pump inhibitor use with the risk of the development or progression of albuminuria among Japanese patients with diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 16)]](/preview/png/8629967.png "First Page Preview: Association of proton pump inhibitor use with the risk of the development or progression of albuminuria among Japanese patients with diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 16)]")
Authors
Yasuaki Hayashino, Shintaro Okamura, Tsuyoshi Mashitani, Satoru Tsujii, Hitoshi Ishii, for the Diabetes Distress and Care Registry at Tenri Study Group for the Diabetes Distress and Care Registry at Tenri Study Group,